Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

Stanford University4 enrolled

Overview

To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).

The investigators will use an automated data integration system to monitor hours per week the CGM is worn and target interventions/troubleshooting techniques as needed. The investigators will use gamification techniques (i.e. ability to gain points and achieve small rewards) to help encourage CGM use and potentially improve glycemic control in this at-risk population.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Type1diabetes

Interventions

gamificationBEHAVIORAL

incentives/rewards and contact between standard visits

Use of Dexcom G5BEHAVIORAL

Dexcom G5 continuous glucose monitor

Eligibility

Sex: ALLMin age: 13 YearsMax age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * type 1 diabetes for more than 6 months * on insulin pump or multiple daily injections without plans to change modality in next 6 months * insured by CCS or Medi-Cal * receiving care at Lucile Packard Children's Hospital or Stanford Children's Health outpatient clinics * English or Spanish-speaking Exclusion Criteria: * major illness or condition that may alter glucose control or ability to complete the study including pregnancy, cystic fibrosis, cancer, liver disease, history of transplant, or hemoglobinopathy * current oral glucocorticoid use * prior use of a CGM system * hemoglobin A1C \<7.5% or \>12% * no wireless internet access

Locations (1)

Stanford Children's

Stanford, California, United States

Outcomes

Primary Outcomes

CGM use

amount of time per week CGM is used

Time frame: baseline to 6 months

Secondary Outcomes

Hgb A1c

glycemic control as measured by Hgb A1c

Time frame: baseline to 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.